标题
Weight gain and antipsychotics: a drug safety review
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 14, Issue 1, Pages 73-96
出版商
Informa Healthcare
发表日期
2014-11-15
DOI
10.1517/14740338.2015.974549
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adverse Events Associated With Psychotropic Treatment in African American Children and Adolescents
- (2015) Jeanette M. Jerrell JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Clozapine: a review of clinical practice guidelines and prescribing trends
- (2014) Stephanie Warnez et al. BMC Psychiatry
- A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults
- (2014) Leslie Citrome et al. CURRENT MEDICAL RESEARCH AND OPINION
- Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder
- (2014) David E. Kemp et al. JOURNAL OF CLINICAL PSYCHIATRY
- A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia
- (2014) H.Y. Meltzer et al. SCHIZOPHRENIA RESEARCH
- A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia
- (2014) Peter J. Weiden et al. SCHIZOPHRENIA RESEARCH
- A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
- (2014) Gang Wang et al. Neuropsychiatric Disease and Treatment
- Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder
- (2013) Heikki Katila et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study
- (2013) Hideaki Katagiri et al. BMC Psychiatry
- The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study
- (2013) Hwang-Bin Lee et al. CLINICAL DRUG INVESTIGATION
- Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia
- (2013) Malcolm Mitchell et al. CLINICAL THERAPEUTICS
- Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations
- (2013) Anja Cerovecki et al. CNS DRUGS
- A review of FDA-approved treatment options in bipolar depression
- (2013) Roger S. McIntyre et al. CNS SPECTRUMS
- Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
- (2013) Andrew J. Cutler et al. CNS SPECTRUMS
- Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review
- (2013) José María Martínez-Ortega et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia
- (2013) C. Schneider et al. EUROPEAN PSYCHIATRY
- Safety of olanzapine use in adolescents
- (2013) Charles Schulz et al. Expert Opinion On Drug Safety
- Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors
- (2013) Rocio Pérez-Iglesias et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Quetiapine in Children and Adolescents With Mania Associated With Bipolar I Disorder
- (2013) Sanjeev Pathak et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics
- (2013) Joseph P. McEvoy et al. JOURNAL OF CLINICAL PSYCHIATRY
- Risk for Adverse Events and Discontinuation Due To Adverse Events of Ziprasidone Monotherapy Relative to Placebo in the Acute Treatment of Bipolar Depression, Mania, and Schizophrenia
- (2013) Keming Gao et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
- (2013) Henry A. Nasrallah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database
- (2013) Chris J Bushe et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
- (2013) Gail L. Daumit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of antipsychotic-induced weight gain: update and current perspectives
- (2013) Amy CC Kao et al. PHARMACOGENOMICS
- Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia
- (2013) Hu Yan et al. PSYCHOPHARMACOLOGY
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
- (2013) T. Scott Stroup et al. SCHIZOPHRENIA RESEARCH
- Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1)
- (2013) Michael J. Peluso et al. SCHIZOPHRENIA RESEARCH
- Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
- (2013) Nagahide Takahashi et al. Neuropsychiatric Disease and Treatment
- Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
- (2013) Glen I. Spielmans et al. PLOS MEDICINE
- Considering metformin in cardiometabolic protection in psychosis
- (2012) J. Curtis et al. ACTA PSYCHIATRICA SCANDINAVICA
- Safety of Low Doses of Quetiapine When Used for Insomnia
- (2012) Holly V Coe et al. ANNALS OF PHARMACOTHERAPY
- Bridging the gap from evidence to policy and practice: Reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication
- (2012) Valsamma Eapen et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)
- (2012) Berit X Carlson et al. BIPOLAR DISORDERS
- Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
- (2012) Mauricio Tohen et al. BRITISH JOURNAL OF PSYCHIATRY
- Atypical Antipsychotic Drugs, Schizophrenia, and Metabolic Syndrome in Non–Euro-American Societies
- (2012) Rami Bou Khalil CLINICAL NEUROPHARMACOLOGY
- Off-Label Use of Atypical Antipsychotics
- (2012) Andrew McKean et al. CNS DRUGS
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- Combination Therapy for Manic Phases: A Critical Review of a Common Practice
- (2012) Pierre Alexis Geoffroy et al. CNS Neuroscience & Therapeutics
- Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study
- (2012) Max Schmauss et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
- (2012) Hoda Moteshafi et al. DRUG SAFETY
- A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
- (2012) Eduard Vieta et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2012) Karla Soares-Weiser et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sertindole in the long-term treatment of schizophrenia
- (2012) Anthony S. Hale et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The effect of atypical antipsychotic medications in individuals with anorexia nervosa: A systematic review and meta-analysis
- (2012) Jocelyn Lebow et al. INTERNATIONAL JOURNAL OF EATING DISORDERS
- Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder
- (2012) Irina Mezhebovsky et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
- (2012) Gavin P. Reynolds et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode
- (2012) Joris Berwaerts et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparison of Long-Term (At Least 24 Weeks) Weight Gain and Metabolic Changes Between Adolescents and Adults Treated with Olanzapine
- (2012) Ludmila A. Kryzhanovskaya et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial
- (2012) Robert L. Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Changes in Weight, Plasma Lipids, and Glucose in Adults Treated With Ziprasidone
- (2012) Elizabeth Pappadopulos et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres
- (2012) Nancy H. Covell et al. JOURNAL OF CLINICAL PSYCHIATRY
- Weight Change From 3-Year Observational Data
- (2012) Chris J. Bushe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Are Antipsychotics Effective for the Treatment of Anorexia Nervosa?
- (2012) Taro Kishi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
- (2012) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders
- (2012) Jian-Ping Zhang et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents
- (2012) David Cohen et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia
- (2012) Andreas Schreiner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Impact of Switching or Initiating Antipsychotic Treatment on Body Weight During a 6-Month Follow-Up in a Cohort of Patients With Schizophrenia
- (2012) Jean-Pierre Schuster et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Rate of Weight Gain and Cardiometabolic Abnormalities in Children and Adolescents
- (2012) Chadi A. Calarge et al. JOURNAL OF PEDIATRICS
- Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature
- (2012) Robert Dent et al. PLoS One
- Weight Gain and Glucose Dysregulation with Second-Generation Antipsychotics and Antidepressants: A Review for Primary Care Physicians
- (2012) Mehrul Hasnain et al. POSTGRADUATE MEDICINE
- The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia
- (2012) Sung-Wan Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
- (2012) Jian-Jun Ou et al. PSYCHOPHARMACOLOGY
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
- (2012) Kieran J. Davey et al. PSYCHOPHARMACOLOGY
- Paliperidone for irritability in adolescents and young adults with autistic disorder
- (2012) Kimberly A. Stigler et al. PSYCHOPHARMACOLOGY
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
- (2012) Bill Montgomery et al. Patient Preference and Adherence
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized, Double-Blind Study of Paliperidone Extended-Release in Treatment of Acute Schizophrenia in Adolescents
- (2011) Jaskaran Singh et al. BIOLOGICAL PSYCHIATRY
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
- (2011) Angela L Hill et al. BMC Psychiatry
- Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial
- (2011) Andrew J. Cutler et al. CLINICAL THERAPEUTICS
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Olanzapine–fluoxetine combination for the treatment of bipolar depression
- (2011) Leslie Citrome EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy of metformin for prevention of weight gain in psychiatric populations
- (2011) Hannah Newall et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis
- (2011) Steven L. Dubovsky et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Weight gain associated with taking psychotropic medication: An integrative review
- (2011) Andrea McCloughen et al. International Journal of Mental Health Nursing
- Safety of amisulpride in combination with antidepressants under common clinical practice conditions
- (2011) Eva Ceskova et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: A randomized, double-blind, placebo- and haloperidol-controlled study
- (2011) Hideaki Katagiri et al. JOURNAL OF AFFECTIVE DISORDERS
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder
- (2011) William G. Honer et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Safety and Tolerability of Antipsychotic Treatment in Young Patients With Schizophrenia
- (2011) Christoph U. Correll JOURNAL OF CLINICAL PSYCHIATRY
- A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder
- (2011) Mary C. Zanarini et al. JOURNAL OF CLINICAL PSYCHIATRY
- Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder
- (2011) Richard H. Weisler et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder
- (2011) Arifulla Khan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Weight gain and lipid-glucose profiles among patients taking antipsychotic medications: comparisons for prescriptions administered using algorithms versus usual care
- (2011) D. A. KOCH et al. Journal of Psychiatric and Mental Health Nursing
- Switching from Quetiapine to Ziprasidone
- (2011) Onur N. Karayal et al. Journal of Psychiatric Practice
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
- (2011) Huafang Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial
- (2011) Ichiro Kusumi et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
- (2011) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- The association between weight change and symptom reduction in the CATIE schizophrenia trial
- (2011) Eric Hermes et al. SCHIZOPHRENIA RESEARCH
- Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
- (2011) Zhang et al. Neuropsychiatric Disease and Treatment
- Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
- (2010) Jorge A. Quiroz et al. BIOLOGICAL PSYCHIATRY
- Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses
- (2010) Carmen Moreno et al. BIPOLAR DISORDERS
- Effectiveness of Switching From Aripiprazole to Ziprasidone in Patients With Schizophrenia
- (2010) Sung-Wan Kim et al. CLINICAL NEUROPHARMACOLOGY
- Pharmacotherapy of Bipolar Disorder in Children and Adolescents
- (2010) Jonathan C. Pfeifer et al. CNS DRUGS
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
- (2010) Michael Liebowitz et al. DEPRESSION AND ANXIETY
- Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia
- (2010) Carla M. Canuso et al. Early Intervention in Psychiatry
- Obesity and coronary risk in patients treated with second-generation antipsychotics
- (2010) Christoph U. Correll et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
- (2010) David Fraguas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders
- (2010) Eduard Parellada et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
- (2010) Srihari Gopal et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder
- (2010) Martin A. Katzman et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
- (2010) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆
- (2010) Brian Bortnick et al. JOURNAL OF AFFECTIVE DISORDERS
- Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: A randomized, double-blind, dose-response study
- (2010) Joris Berwaerts et al. JOURNAL OF AFFECTIVE DISORDERS
- Age-Dependent Metabolic Effects of Second-Generation Antipsychotics in Second-Generation Antipsychotic-Naïve French Canadian Patients
- (2010) Geneviève Roy et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics
- (2010) Keming Gao et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder
- (2010) Carla M. Canuso et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)
- (2010) Susan L. McElroy et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Sertindole and Risperidone in Patients With Treatment-Resistant Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)
- (2010) Allan H. Young et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Paliperidone Extended-Release in Schizoaffective Disorder
- (2010) Carla M. Canuso et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
- (2010) Gahan J. Pandina et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Predictive Value of Early Changes in Triglycerides and Weight for Longer-Term Changes in Metabolic Measures During Olanzapine, Ziprasidone or Aripiprazole Treatment for Schizophrenia and Schizoaffective Disorder
- (2010) Vicki P. Hoffmann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials
- (2010) Brian A Millen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics
- (2010) Olawale Osuntokun et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
- (2010) Henry A Nasrallah et al. NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
- (2010) Leslie Citrome POSTGRADUATE MEDICINE
- A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone
- (2010) Seung-Yup Lee et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
- (2010) Gahan Pandina et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics
- (2010) William V. Bobo et al. PSYCHIATRY RESEARCH
- A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia
- (2010) Herbert Y. Meltzer et al. PSYCHIATRY RESEARCH
- A head-to-head comparison of sertindole and risperidone on metabolic parameters
- (2010) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia: Women Bear a Disproportionate Toll of Antipsychotic Side Effects
- (2010) Mary V. Seeman Journal of the American Psychiatric Nurses Association
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain
- (2009) Trino Baptista et al. CNS DRUGS
- Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
- (2009) Borwin Bandelow et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
- (2009) Michelle Kramer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
- (2009) Trisha Suppes et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia
- (2009) C. Bushe et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Weight gain in antipsychotic-naive patients: a review and meta-analysis
- (2009) I. Tarricone et al. PSYCHOLOGICAL MEDICINE
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
- (2008) W. Wolfgang Fleischhacker et al. BIOLOGICAL PSYCHIATRY
- Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study
- (2008) E. Vieta et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now